{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:42:15Z","timestamp":1790991735324,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00415-020-10033-z","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T09:40:41Z","timestamp":1593596441000},"page":"3499-3507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"267","author":[{"given":"Taylor","family":"Pindi Sala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Villedieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Damian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Crave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Pautot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljudmila","family":"Stojanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cherin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Belizna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"10033_CR1","first-page":"1","volume":"25","author":"A Binard","year":"2007","unstructured":"Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A (2007) Epidemiology of Sj\u00f6gren's syndrome: where are we now? Clin Exp Rheumatol 25:1\u20134","journal-title":"Clin Exp Rheumatol"},{"key":"10033_CR2","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.24311","volume":"59","author":"B Segal","year":"2008","unstructured":"Segal B, Thomas W, Rogers T et al (2008) Prevalence, severity, and predictors of fatigue in subjects with primary Sj\u00f6gren's syndrome. Arthritis Rheum 59:1780\u20131787","journal-title":"Arthritis Rheum"},{"key":"10033_CR3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, GEMESS Study Group et al (2008) Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 87:210\u2013219","journal-title":"Medicine"},{"key":"10033_CR4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","volume":"82","author":"PP Pavlakis","year":"2011","unstructured":"Pavlakis PP, Alexopoulos H, Kosmidis ML et al (2011) Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 82:798\u2013802","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","volume":"128","author":"K Mori","year":"2005","unstructured":"Mori K, Iijima M, Koike H et al (2005) The wide spectrum of clinical manifestations in Sj\u00f6gren's syndrome-associated neuropathy. Brain 128:2518\u20132534","journal-title":"Brain"},{"key":"10033_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, de Seze J, Fauchais AL et al (2004) Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine 83:280\u2013291","journal-title":"Medicine"},{"key":"10033_CR7","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","volume":"131","author":"G Devigili","year":"2008","unstructured":"Devigili G, Tugnoli V, Penza P et al (2008) The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131:1912\u20131925","journal-title":"Brain"},{"key":"10033_CR8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0404.1995.tb00150.x","volume":"92","author":"KC Gorson","year":"1995","unstructured":"Gorson KC, Ropper AH (1995) Idiopathic distal small fiber neuropathy. Acta Neurol Scand 92:376\u2013382","journal-title":"Acta Neurol Scand"},{"key":"10033_CR9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.2006.091074","volume":"77","author":"EA De Sousa","year":"2006","unstructured":"De Sousa EA, Hays AP, Chin RL, Sander HW, Brannagan TH (2006) Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy. J Neurol Neurosurg Psychiatry 77:983\u2013985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.wnl.0000176034.38198.f9","volume":"65","author":"J Chai","year":"2005","unstructured":"Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL (2005) Painful small-fiber neuropathy in Sjogren syndrome. Neurology 65:925\u2013927","journal-title":"Neurology"},{"key":"10033_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrneurol.2012.97","volume":"8","author":"JG Hoeijmakers","year":"2012","unstructured":"Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG (2012) Small-fibre neuropathies\u2014advances in diagnosis, pathophysiology and management. Nat Rev Neurol 8:369\u2013379","journal-title":"Nat Rev Neurol"},{"key":"10033_CR12","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2012-2597","volume":"131","author":"AL Oaklander","year":"2013","unstructured":"Oaklander AL, Klein MM (2013) Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes. Pediatrics 131:e1091\u2013e1100","journal-title":"Pediatrics"},{"key":"10033_CR13","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00415-016-8270-5","volume":"263","author":"M Lang","year":"2016","unstructured":"Lang M, Treister R, Oaklander AL (2016) Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol 263:2515\u20132527","journal-title":"J Neurol"},{"key":"10033_CR14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","volume":"19","author":"D Moulin","year":"2014","unstructured":"Moulin D, Boulanger A, Clark AJ, Canadian Pain Society et al (2014) Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 19:328\u2013335","journal-title":"Pain Res Manag"},{"key":"10033_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jnnp.2007.128801","volume":"79","author":"KC Gorson","year":"2008","unstructured":"Gorson KC, Herrmann DN, Thiagarajan R et al (2008) Non-length dependent small fibre neuropathy\/ganglionopathy. J Neurol Neurosurg Psychiatry 79:163\u2013169","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1085-9489.2006.00062.x","volume":"11","author":"R Dabby","year":"2006","unstructured":"Dabby R, Gilad R, Sadeh M, Lampl Y, Watemberg N (2006) Acute steroid responsive small-fiber sensory neuropathy: a new entity? J Peripher Nerv Syst 11:47\u201352","journal-title":"J Peripher Nerv Syst"},{"key":"10033_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00296-007-0396-4","volume":"28","author":"P S\u00e8ve","year":"2007","unstructured":"S\u00e8ve P, Gachon E, Petiot P, Stankovic K, Charhon A, Broussolle C (2007) Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sj\u00f6gren's syndrome. Rheumatol Int 28:175\u2013177","journal-title":"Rheumatol Int"},{"key":"10033_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2011-200086","volume":"71","author":"A Mekinian","year":"2012","unstructured":"Mekinian A, Ravaud P, Hatron PY et al (2012) Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis 71:84\u201387","journal-title":"Ann Rheum Dis"},{"key":"10033_CR19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","volume":"19","author":"D Wakasugi","year":"2009","unstructured":"Wakasugi D, Kato T, Gono T et al (2009) Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sj\u00f6gren's syndrome. Mod Rheumatol 19:437\u2013440","journal-title":"Mod Rheumatol"},{"key":"10033_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","volume":"279","author":"S Morozumi","year":"2009","unstructured":"Morozumi S, Kawagashira Y, Iijima M et al (2009) Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sj\u00f6gren's syndrome. J Neurol Sci 279:57\u201361","journal-title":"J Neurol Sci"},{"key":"10033_CR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","volume":"60","author":"JA Molina","year":"1996","unstructured":"Molina JA, Benito-Le\u00f3n J, Bermejo F, Jim\u00e9nez-Jim\u00e9nez FJ, Oliv\u00e1n J (1996) Intravenous immunoglobulin therapy in sensory neuropathy associated with Sj\u00f6gren's syndrome. J Neurol Neurosurg Psychiatry 60:699","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","volume":"77","author":"M Kizawa","year":"2006","unstructured":"Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G (2006) Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sj\u00f6gren's syndrome. J Neurol Neurosurg Psychiatry 77:967\u2013969","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR23","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367\u20132375","journal-title":"JAMA"},{"key":"10033_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, European Study Group on Classification Criteria for Sj\u00f6gren's Syndrome et al (2002) Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10033_CR25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"G Lauria","year":"2010","unstructured":"Lauria G, Hsieh ST, Johansson O, Kennedy WR et al (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the Use of Skin Biopsy in the Diagnosis of Small Fiber Neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 17(7):903\u2013912","journal-title":"Eur J Neurol."},{"key":"10033_CR26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1468-1331.2008.02305.x","volume":"15","author":"N Souayah","year":"2008","unstructured":"Souayah N, Chin RL, Brannagan TH et al (2008) Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol 15:1300\u20131303","journal-title":"Eur J Neurol"},{"key":"10033_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2010.09.015","volume":"105","author":"JG Parambil","year":"2011","unstructured":"Parambil JG, Tavee JO, Zhou L, Pearson KS, Culver DA (2011) Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 105:101\u2013105","journal-title":"Respir Med"},{"key":"10033_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","volume":"7","author":"RA Hughes","year":"2008","unstructured":"Hughes RA, Donofrio P, Bril V, ICE Study Group et al (2008) Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 7:136\u2013144","journal-title":"Lancet Neurol"},{"key":"10033_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jns5.12017","volume":"18","author":"JM L\u00e9ger","year":"2013","unstructured":"L\u00e9ger JM, De Bleecker JL, Sommer C, PRIMA study investigators et al (2013) Efficacy and safety of Privigen(\u00ae) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). J Peripher Nerv Syst. 18:130\u2013140","journal-title":"J Peripher Nerv Syst."},{"key":"10033_CR30","first-page":"127","volume":"51","author":"T Kubori","year":"1999","unstructured":"Kubori T, Mezaki T, Kaji R et al (1999) The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy]. No To Shinkei 51:127\u2013135","journal-title":"No To Shinkei"},{"key":"10033_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","volume":"17","author":"IN van Schaik","year":"2018","unstructured":"van Schaik IN, Bril V, van Geloven N, PATH Study Group et al (2018) Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 17:35\u201346","journal-title":"Lancet Neurol"},{"key":"10033_CR32","first-page":"CD003280","volume":"5","author":"M Mahdi-Rogers","year":"2017","unstructured":"Mahdi-Rogers M, Brassington R, Gunn AA, van Doorn PA, Hughes RA (2017) Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 5:CD003280","journal-title":"Cochrane Database Syst Rev"},{"key":"10033_CR33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FG van der Meche","year":"1992","unstructured":"van der Meche FG, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 326:1123\u20131129","journal-title":"N Engl J Med"},{"key":"10033_CR34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.313.7054.376","volume":"313","author":"RA Hughes","year":"1996","unstructured":"Hughes RA (1996) Intravenous IgG in Guillain-Barr\u00e9 syndrome. BMJ 313:376\u2013377","journal-title":"BMJ"},{"key":"10033_CR35","doi-asserted-by":"crossref","first-page":"e3632","DOI":"10.1097\/MD.0000000000003632","volume":"95","author":"PR Pereira","year":"2016","unstructured":"Pereira PR, Viala K, Maisonobe T et al (2016) Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine 95:e3632","journal-title":"Medicine"},{"key":"10033_CR36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","volume":"60","author":"Y Takahashi","year":"2003","unstructured":"Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I (2003) Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren\u2019s syndrome. IV immunoglobulin. Neurology 60:503\u2013505","journal-title":"Neurology"},{"key":"10033_CR37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","volume":"63","author":"S Rist","year":"2011","unstructured":"Rist S, Sellam J, Hachulla E et al (2011) Club Rhumatismes et inflammation. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sj\u00f6gren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken) 63:1339\u20131344","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10033_CR38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NRL.0b013e3181ebe59f","volume":"16","author":"J Birnbaum","year":"2010","unstructured":"Birnbaum J (2010) Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 16:287\u2013297","journal-title":"Neurologist"},{"key":"10033_CR39","doi-asserted-by":"crossref","first-page":"175628561774448","DOI":"10.1177\/1756285617744484","volume":"11","author":"X Liu","year":"2018","unstructured":"Liu X, Treister T, Lang M, Oaklander AL (2018) IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety. Ther Adv Neurol Disord 11:1756285617744484","journal-title":"Ther Adv Neurol Disord"},{"key":"10033_CR40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13063-016-1450-x","volume":"17","author":"BT de Greef","year":"2016","unstructured":"de Greef BT, Geerts M, Hoeijmakers JG, Faber CG, Merkies IS (2016) Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial. Trials 17:330","journal-title":"Trials"},{"key":"10033_CR41","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/jnnp.2010.206599","volume":"81","author":"K Kuitwaard","year":"2010","unstructured":"Kuitwaard K, van den Berg LH, Vermeulen M et al (2010) Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 81:1374\u20131379","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10033_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2011.05.035","volume":"308","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Kearney DA (2011) Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: a two-year study. J Neurol Sci 308:124\u2013127","journal-title":"J Neurol Sci"},{"key":"10033_CR43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IJCTM.S94329","volume":"4","author":"M Mohamed","year":"2016","unstructured":"Mohamed M (2016) Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions. Int J Clin Transfus Med 4:121\u2013131","journal-title":"Int J Clin Transfus Med"},{"key":"10033_CR44","first-page":"CD004429","volume":"18","author":"IN van Schaik","year":"2005","unstructured":"van Schaik IN, van den Berg LH, de Haan R, Vermeulen M (2005) Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev 18:CD004429","journal-title":"Cochrane Database Syst Rev"},{"key":"10033_CR45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1529-8027.2006.00105.x","volume":"11","author":"YA Rajabally","year":"2006","unstructured":"Rajabally YA, Seow H, Wilson P (2006) Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 11:325\u2013329","journal-title":"J Peripher Nerv Syst"},{"key":"10033_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jns.12158","volume":"21","author":"MP Lunn","year":"2016","unstructured":"Lunn MP, Ellis L, Hadden RD, Rajabally YA, Winer JB, Reilly MM (2016) A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. J Peripher Nerv Syst 21:33\u201337","journal-title":"J Peripher Nerv Syst"},{"key":"10033_CR47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jns.12267","volume":"23","author":"DR Cornblath","year":"2018","unstructured":"Cornblath DR, Hartung HP, Katzberg HD, Merkies ISJ, van Doorn PA (2018) A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. J Peripher Nerv Syst 23:108\u2013114","journal-title":"J Peripher Nerv Syst"},{"key":"10033_CR48","first-page":"S109","volume":"78","author":"AL Oaklander","year":"2015","unstructured":"Oaklander AL, Lang M, Treister R, Liu X (2015) First evaluation of immunoglobulin treatment of small-fiber axonal polyneuropathy (SFPN). Ann Neurol 78:S109","journal-title":"Ann Neurol"},{"key":"10033_CR49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2015.12.003","volume":"15","author":"P Cherin","year":"2016","unstructured":"Cherin P, Belizna C, Cartry O et al (2016) Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases. Autoimmun Rev 15:281\u2013286","journal-title":"Autoimmun Rev"},{"key":"10033_CR50","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00415-014-7444-2","volume":"261","author":"D Cocito","year":"2014","unstructured":"Cocito D, Merola A, Peci E et al (2014) SCIg and chronic dysimmune neuropathies Italian Network. Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. J Neurol. 261:2159\u20132164","journal-title":"J Neurol."},{"key":"10033_CR51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mus.25409","volume":"55","author":"JM Racosta","year":"2017","unstructured":"Racosta JM, Sposato LA, Kimpinski K (2017) Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: a meta-analysis. Muscle Nerve 55:802\u2013809","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10033-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T02:21:51Z","timestamp":1625106111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10033-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10033"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10033-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study is not industry sponsored. Dr. Pindi Sala reports no disclosures. Mrs Mona Villedieu reports no disclosures. Dr Laura Damian reports no disclosures. Mr Jean-Charles Crave reports no disclosures. Dr Vivien Pautot reports no disclosures. Professor Ljudmila Stojanovich reports no disclosures. Professor Jan Willem Cohen Tervaert reports no disclosures. Professor Patrick Cherin reports no disclosures. Dr. Cristina Belizna reports no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"No ethics committee approval was required for this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As per local legislation, patients were informed that data from their treatment may be reported and did not refuse the anonymous dissemination of this information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}